HK1204290A1 - Materials and methods for treating diarrhea - Google Patents

Materials and methods for treating diarrhea Download PDF

Info

Publication number
HK1204290A1
HK1204290A1 HK15104949.7A HK15104949A HK1204290A1 HK 1204290 A1 HK1204290 A1 HK 1204290A1 HK 15104949 A HK15104949 A HK 15104949A HK 1204290 A1 HK1204290 A1 HK 1204290A1
Authority
HK
Hong Kong
Prior art keywords
amino acid
present
materials
acid formulation
methods
Prior art date
Application number
HK15104949.7A
Other languages
English (en)
Chinese (zh)
Inventor
Sadasivan Vidyasagar
Paul Okunieff
Lurong Zhang
Original Assignee
University Of Florida Research Foundation, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Florida Research Foundation, Inc. filed Critical University Of Florida Research Foundation, Inc.
Publication of HK1204290A1 publication Critical patent/HK1204290A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15104949.7A 2012-02-08 2013-02-08 Materials and methods for treating diarrhea HK1204290A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261596480P 2012-02-08 2012-02-08
US61/596,480 2012-02-08
PCT/US2013/025294 WO2013119917A1 (en) 2012-02-08 2013-02-08 Materials and methods for treating diarrhea

Publications (1)

Publication Number Publication Date
HK1204290A1 true HK1204290A1 (en) 2015-11-13

Family

ID=48948047

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104949.7A HK1204290A1 (en) 2012-02-08 2013-02-08 Materials and methods for treating diarrhea

Country Status (15)

Country Link
US (4) US20140377374A1 (enrdf_load_stackoverflow)
EP (1) EP2812007B1 (enrdf_load_stackoverflow)
JP (1) JP6084238B2 (enrdf_load_stackoverflow)
KR (2) KR20140120941A (enrdf_load_stackoverflow)
CN (1) CN104093410B (enrdf_load_stackoverflow)
AP (1) AP3941A (enrdf_load_stackoverflow)
AU (1) AU2013216871B2 (enrdf_load_stackoverflow)
BR (1) BR112014019350B1 (enrdf_load_stackoverflow)
CA (1) CA2863388C (enrdf_load_stackoverflow)
EA (1) EA034014B1 (enrdf_load_stackoverflow)
ES (1) ES2862392T3 (enrdf_load_stackoverflow)
HK (1) HK1204290A1 (enrdf_load_stackoverflow)
IN (1) IN2014DN06737A (enrdf_load_stackoverflow)
MX (1) MX368543B (enrdf_load_stackoverflow)
WO (1) WO2013119917A1 (enrdf_load_stackoverflow)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3970715A1 (en) 2010-09-24 2022-03-23 University of Florida Research Foundation, Inc. Materials and methods for improving gastrointestinal function
CN110522744B (zh) 2013-03-11 2023-04-07 佛罗里达大学研究基金会有限公司 用于改善肺功能和用于预防和/或治疗辐射诱发的肺并发症的材料和方法
EP3459540A1 (en) 2014-11-24 2019-03-27 Entrinsic Health Solutions, Inc. Amino acid compositions for the treatment of symptoms of disease
CA3135553C (en) 2016-10-04 2024-05-21 University Of Florida Research Foundation, Incorporated Amino acid compositions and uses thereof
WO2019070753A1 (en) * 2017-10-02 2019-04-11 University Of Florida Research Foundation, Incorporated AMINO ACID COMPOSITIONS AND METHODS FOR TREATING DIARRHEA
CN115916185B (zh) * 2020-06-02 2025-09-26 佛罗里达大学研究基金会公司 用于治疗腹泻的制剂和方法
JP2023533617A (ja) 2020-07-02 2023-08-03 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド 水分補給を促進するための製剤およびその使用方法
CN118369093A (zh) * 2021-05-28 2024-07-19 可口可乐公司 氨基酸水合配制品及使用方法
CN115531363B (zh) * 2021-06-30 2024-03-29 中国科学技术大学 预防、抑制或治疗轮状病毒感染的药物组合物及其用途
US11878073B1 (en) 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290538A (en) * 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
JP3301646B2 (ja) * 1993-03-19 2002-07-15 シスメックス株式会社 幼若細胞測定用試薬
CA2218074C (en) * 1995-04-14 2002-10-08 Mohammed Eljamal Powdered pharmaceutical formulations having improved dispersibility
JP4255656B2 (ja) * 2001-09-17 2009-04-15 株式会社メニコン 眼科用液剤及びコンタクトレンズ用液剤
US20030143293A1 (en) * 2002-01-31 2003-07-31 Sergei Shushunov Compositions and methods for treating diarrhea
JP2004123642A (ja) * 2002-10-04 2004-04-22 Shimizu Pharmaceutical Co Ltd 電解質組成物
DK175877B1 (da) * 2002-11-11 2005-05-09 Pharmalett As Præparater til anvendelse som terapeutisk middel
US20050100637A1 (en) * 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
GB0503337D0 (en) * 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
JP4811576B2 (ja) * 2005-03-31 2011-11-09 味の素株式会社 水分電解質補給飲料
JP4512013B2 (ja) * 2005-09-07 2010-07-28 和光堂株式会社 液体飲料組成物及びその製造方法
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
EP3970715A1 (en) * 2010-09-24 2022-03-23 University of Florida Research Foundation, Inc. Materials and methods for improving gastrointestinal function
CN110522744B (zh) * 2013-03-11 2023-04-07 佛罗里达大学研究基金会有限公司 用于改善肺功能和用于预防和/或治疗辐射诱发的肺并发症的材料和方法

Also Published As

Publication number Publication date
MX368543B (es) 2019-10-07
KR20140120941A (ko) 2014-10-14
KR102262179B1 (ko) 2021-06-07
US20210299076A1 (en) 2021-09-30
EA201400827A1 (ru) 2014-12-30
US20150297636A1 (en) 2015-10-22
BR112014019350B1 (pt) 2020-09-24
JP6084238B2 (ja) 2017-02-22
AP3941A (en) 2016-12-16
US20140377374A1 (en) 2014-12-25
CA2863388A1 (en) 2013-08-15
CA2863388C (en) 2020-11-17
EP2812007A1 (en) 2014-12-17
EA034014B1 (ru) 2019-12-19
MX2014009557A (es) 2014-11-10
BR112014019350A8 (pt) 2017-07-11
JP2015506981A (ja) 2015-03-05
AU2013216871B2 (en) 2017-08-17
WO2013119917A1 (en) 2013-08-15
CN104093410B (zh) 2018-04-27
KR20200105525A (ko) 2020-09-07
EP2812007B1 (en) 2020-12-30
AP2014007916A0 (en) 2014-09-30
IN2014DN06737A (enrdf_load_stackoverflow) 2015-05-22
AU2013216871A1 (en) 2014-09-11
CN104093410A (zh) 2014-10-08
US20250073260A1 (en) 2025-03-06
ES2862392T3 (es) 2021-10-07
BR112014019350A2 (enrdf_load_stackoverflow) 2017-06-20
EP2812007A4 (en) 2015-09-09

Similar Documents

Publication Publication Date Title
HK1204290A1 (en) Materials and methods for treating diarrhea
MX352823B (es) Formulaciones de proteinas que contienen aminoacidos.
EP4417256A3 (en) Materials and methods for improving lung function
BR112015008186A2 (pt) formulação de um anticorpo estável e de baixa viscosidade
WO2011109365A3 (en) Concentrated protein formulations and uses thereof
WO2014141152A3 (en) Low concentration antibody formulations
HK1206370A1 (en) Charged nutritive proteins and methods
MX2014000064A (es) Composicion detergente liquido.
BR112012018023A2 (pt) formulações líquidas que contêm anticorpo estabilizado.
WO2010101625A3 (en) Oxygen sensor
BR112014010222A2 (pt) formulação de enzima líquida e processo para sua preparação
EP4233892A3 (en) Stable anti-ifnar1 formulation
HRP20190751T1 (hr) Pripravci i postupci korisni za stabilizaciju formulacija koje sadrže proteine
PE20141151A1 (es) Proteinas de union al antigeno cd27l
HK1206763A1 (en) Charged nutritive fragments, proteins and methods
EA201590061A1 (ru) Фармацевтическая композиция
HRP20220626T1 (hr) Otopine bimatoprosta i timolola bez konzervansa
BR112014026483A2 (pt) composição antimicrobiana, composição antimicrobiana bicomponente, pano de limpeza, método para desinfetar uma superfície e método para controlar esporos sobre uma superfície
ZA201602253B (en) Solutons for increasing the stability and shelf life of an organ and tissue preservation solution
TR201907379T4 (tr) Yeni anti-insan PAI-1 antikoru.
WO2013081471A3 (en) Facile laboratory method for localising biomolecules to the surface of cells and viruses
EA201401200A1 (ru) Новая композиция альфентанила для лечения острой боли
WO2013120106A3 (en) Amino acid copolymer assay
PH12013502250A1 (en) Construction material preservative
WO2014055977A3 (en) Modulation of branched amino acid concentrations